Skip to content
APOAPOAPOELELEL505050

Drawing based on the description in the official product monograph. No photo yet.

“50 mg tablets are available in brown, round, biconvex coated tablet engraved "APO" on one side, "EL" over "50" on the other side”

APO EL 50 pill

Pill with imprint APO EL 50 is brown, round and has been identified as Eltrombopag Olamine 50 mg. It is used for aplastic anemia and idiopathic thrombocytopenic purpura. It is supplied by Apotex Inc.

Sold in Canada

Eltrombopag Olamine 50 mg

Brand
Apo-Eltrombopag
Imprint
APO EL 50
Strength
50 mg
Used for
Aplastic anemia and idiopathic thrombocytopenic purpura
Color
Brown
Shape
Round
Form
Tablet
Manufacturer
Apotex Inc
Drug class
Thrombopoietin receptor agonist
Sold in
Canada
DIN
02506769

Source: Health Canada's Drug Product Database and the official product monograph. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Eltrombopag Olamine pills and guides

What is Eltrombopag Olamine used for?

Eltrombopag Olamine is used for aplastic anemia and idiopathic thrombocytopenic purpura.

Medicine type
Thrombopoietin receptor agonist
Official uses from the US prescribing label

Treatment of Thrombocytopenia in Patients With Persistent or Chronic Immune Thrombocytopenia

Eltrombopag tablets are indicated for the treatment of thrombocytopenia in adult and pediatric patients 1 year and older with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. Eltrombopag tablets should be used only in patients with ITP whose degree of thrombocytopenia and clinical condition increase the risk for bleeding.

Treatment of Thrombocytopenia in Patients With Hepatitis C Infection

Eltrombopag tablets are indicated for the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy. Eltrombopag tablets should be used only in patients with chronic hepatitis C whose degree of thrombocytopenia prevents the initiation of interferon-based therapy or limits the ability to maintain interferon-based therapy.

Treatment of Severe Aplastic Anemia

  • Eltrombopag tablets are indicated in combination with standard immunosuppressive therapy (IST) for the first-line treatment of adult and pediatric patients 2 years and older with severe aplastic anemia.
  • Eltrombopag tablets are indicated for the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.

Limitations of Use

  • Eltrombopag tablets are not indicated for the treatment of patients with myelodysplastic syndromes (MDS).
  • Safety and efficacy have not been established in combination with direct-acting antiviral agents used without interferon for treatment of chronic hepatitis C infection.

From the FDA-approved label on DailyMed (published Sep 14, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows APO EL 50. The parts can be split between the two sides, so turn the pill over and check both.
  • It is brown, round.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold in Canada as Apo-Eltrombopag by Apotex Inc.

In Canada: prescription only.

Ingredients

Active: Eltrombopag (Eltrombopag Olamine)

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Eltrombopag Olamine pills